| Profile for vitisribibumfsig |
|---|
|
SignatureIntermittent (Sarafem): 20 mg PO qDay starting 14 days before menstruation and through first full day of menses (repeat each cycle).Use caution in patients with history of seizure disorders. May prolong QT interval and cause ventricular arrhythmia, including torsade de pointes.... |
